I'm a quality and compliance manager at a diagnostics company that makes clinical chemistry analyzers, hematology analyzers, immunoassay analyzers, centrifuges, flow cytometers, mass spectrometers, and life sciences automation tools. I review roughly 200 unique deliverables a year: user manuals, online product pages, package inserts, test menus, part number changes. In 2024, I rejected about 11% of first deliveries because the documentation didn't match the specification. That number isn't a trophy. It's a warning about how easily good enough becomes a habit.
Here's my opinion, and I'll put it plainly: No customer should get lower-quality support just because their order is small. A single Beckman Coulter centrifuge manual order from an independent lab deserves the same verification as a 50,000-unit contract. Small doesn't mean unimportant. It means potential.
The manual that changed how I look at small orders
I didn't always feel this way. Early in my career, I focused on the big-ticket items: complex analyzers, validation runs, multimillion-dollar installations. A manual seemed like background noise. Then, in Q1 2024, we received a batch of user guides where the rotor speed table didn't match the current firmware version. Normal tolerance for documentation is zero. If the speed is wrong, the operator can't know whether the centrifuge is safe to use.
That batch included one guide for a Beckman Coulter centrifuge and several other product guides. In dollars, it was a small order. We rejected the batch anyway, sent it back, and the vendor redid it at their cost. Now every contract with that vendor includes a document-verification requirement. According to ISO 15189:2022, medical laboratories need to manage documents and records carefully; a missing or outdated manual is not just annoying for a small lab, it can become a compliance gap.
Honestly, I'm not sure why documentation is so often the first thing to slip. My best guess is that teams treat it as a boring last step instead of part of the medical device itself. But a lab technician searching for a Beckman Coulter centrifuge manual at 3 a.m. is not a boring task. It's a patient result waiting to happen.
The Access 2 test list is not a marketing document
Another example: a lab trying to decide whether to bring in a new immunoassay analyzer. They don't want vague promises. They want to see exactly which tests are available, which sample types are validated, and whether their highest-volume assays are on the menu. The Beckman Coulter Access 2 test list is one of the first things I tell people to check. In my experience, the lab that checks that list carefully is usually the one that asks better questions throughout the entire purchasing process. In that same 2024 audit, the smaller labs were the ones asking sharper questions about reference ranges than the big accounts. That's not what I expected, but it's been consistent.
I went back and forth on whether to make test-menu verification a formal step in our quality review. On one hand, the sales team is responsible for presenting the menu. On the other, I've seen too many procurement mistakes happen when someone relies on an outdated brochure. Ultimately, we made it a formal step. It took a little extra time, and our customer questions dropped noticeably.
If you're a small lab, the practical takeaway is simple: download the current Beckman Coulter Access 2 test list from the manufacturer's site, check the date, and compare it with your actual test volume. Don't assume the printed list from last year is still right. I've never fully understood why some vendors distribute outdated menus, but I've learned to double-check everything.
When the patient journey is messy, standards matter more
Here's the part that caught me off guard when I started in diagnostics quality: the instrument is only one piece of a patient's story. A clinician who orders a CBC might be treating someone with an implanted vagus nerve stimulator, monitoring recovery after ostomy surgery, or reviewing results from a sleep diagnostic device. None of those products are ours. We don't sell them, and we don't claim to be experts in them. But the patient still ends up in a lab that uses our analyzer.
That means our documentation has to work in a messy world. A lab tech in a small clinic may not have a dedicated biomed team. They may need to find a Beckman Coulter centrifuge manual, confirm a protocol in the Beckman Coulter Access 2 test list, and troubleshoot a sample issue all in the same shift. If instructions are buried in a customer portal or written only for an expert with 20 years of experience, we're creating risk, not reducing it.
This is why I get defensive when someone says it's just an accessory. Ostomy supplies, sleep diagnostic devices, and vagus nerve stimulators all matter enormously to specific patients. They may not be part of our portfolio, but they're part of our customers' reality. A diagnostics company that ignores that reality is building for a lab that doesn't exist.
The cost objection, and why it doesn't hold up
Now let me address the pushback I expect: small orders are more expensive to serve proportionally. You can't run a business if you treat every $200 manual order like a $200,000 system. I get that. Some amount of tiering is reasonable; large customers often need dedicated account teams. But tiering should never mean worse quality.
A smaller lab can't absorb a bad batch as easily as a large reference laboratory. The risk is actually higher. In 2022, I implemented a verification protocol for small-order literature because we kept seeing one-sheet inserts with outdated reference ranges. The change added about 12 minutes of inspection time per item. That's a small cost for catching errors that could lead to a misdiagnosis.
I won't pretend a manual order costs the same to support as a whole instrument installation. But that doesn't justify a punitive price or a dismissive response. It justifies honest packaging, clear lead times, and help that actually arrives. Granted, this requires more upfront work. It also means saying no to some fast-turnaround requests. But when an independent clinic asks my opinion on equipment, I don't say call the big vendor and hope they pay attention. I say look at the test menu, read the centrifuge manual, and ask how you'll get help on a weekend. That's the standard I want for every customer, including the ones whose first order is a single manual.
A small order is a small test, not a small promise
Even after making these changes, I kept second-guessing. What if the extra checks slowed down shipments and annoyed distributors? The first week was stressful. Then a small lab sent a note saying the package insert finally matched their instrument's software version. I don't know if that note reached the sales team, but it was enough for me.
So here's my position: treat every order like it could become a long-term partnership, because it probably will. I've seen independent labs start with a single Beckman Coulter centrifuge manual and later standardize broader parts of their laboratory on our systems. I've also seen large accounts walk away over a missing screw. Order size tells you about a customer's current capacity, not their potential.
Bottom line: whether someone is buying an instrument, checking the Beckman Coulter Access 2 test list, or supporting a patient who uses ostomy supplies, a sleep diagnostic device, or a vagus nerve stimulator, the standard should not change. Small doesn't mean unimportant. It means potential.
Ask a laboratory operations question
Use the contact form if the question involves analyzer selection, service coverage, LIS integration, or validation files. Do not include patient information.